Figures 5E, F show how knocking down CD164 stops breast cancer cells in the S-phase of the cell cycle. In addition, Annexin V/PI staining showed a clear rise in death after si-CD164 treatment as opposed to the si-NC group (Figures 5G, H). This evidence concerns the gene ANXA5 and breast carcinoma.